You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Litigation Details for Exelixis, Inc. v. Teva Pharmaceutical Industries Limited (D. Del. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Exelixis, Inc. v. Teva Pharmaceutical Industries Limited
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for Exelixis, Inc. v. Teva Pharmaceutical Industries Limited (D. Del. 2021)

Date Filed Document No. Description Snippet Link To Document
2021-06-17 1 Complaint of U.S. Patent Nos. 9,724,342, 10,039,757, and 10,034,873 (collectively, the “Asserted Patents”). … The ’757 Patent will expire on July 18, 2031. 29. U.S. Patent No. 10,034,873 (the “’873… COUNT III: INFRINGEMENT OF US PATENT NO. 10,034,873 58. Exelixis incorporates …FOR PATENT INFRINGEMENT 1. This is an action for patent infringement under the patent laws…the ’342 Patent, at least claim 1 of the ’757 Patent, and at least claim 1 of the ’873 Patent. The Asserted External link to document
2021-08-27 13 Answer to Complaint U.S. Patent Nos. 9,724,342 (the “’342 Patent”); 10,039, 757 (the “’757 Patent”); and 10,034,873 (the…U.S. Patent Nos. 9,724,342 (the “’342 Patent”), 10,039,757 (the “’757 Patent”), and 10,034,873 (the…DEFENSE: INVALIDITY OF US PATENT NO. 10,034,873 Each claim of the ’873 Patent is invalid for failing…Certification Concerning U.S. Patent Nos. 9,724,342, 10,039,757 and 10,034,873” (the “First Notice Letter…Certification Concerning U.S. Patent Nos. 9,724,342, 10,039,757 and 10,034,873” (the “Second Notice Letter External link to document
2021-06-17 3 ANDA Form 10,039,757 and Patent No. 10,034,873). Thirty Month Stay Deadline: On or about: 11/4/2023. (mal) (Entered: 06/21…of Expiration of Patents: July 9, 2033 (Patent No. 9,724,342) and July 18, 2031 (Patent No. 10,039,757 … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 11 February 2022 1:21-cv-00871 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-06-17 4 Patent/Trademark Report to Commissioner Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,724,342 ;10,039,757 ;10,034,873. (mal) … 11 February 2022 1:21-cv-00871 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.